(Q45205104)
Statements
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (English)
Bradley A Schiff
Andrea B McMurphy
Samar A Jasser
Maher N Younes
Dao Doan
Orhan G Yigitbasi
Seungwon Kim
Ge Zhou
Benjamin N Bekele
F Christopher Holsinger
Sai-Ching Yeung
Adel K El-Naggar